APAICS lists Novo Nordisk as a partner on webpages for events in March and May where panel discussions touched on the treatment of obesity.

Source: https://northdenvernews.com/seeking-medicare-coverage-for-weight-loss-drugs-pharma-giant-courts-black-influencers/

Because Wegovy is not yet available in Canada — and Novo Nordisk has not given a date when it will be — some doctors are prescribing Ozempic at higher doses for their patients suffering from obesity.

Source: https://www.100milefreepress.net/trending-now/despite-social-media-buzz-ozempic-is-not-a-quick-fix-weight-loss-solution-doctors/

BlackRock Inc. boosted its stake in Novo Nordisk A/S by 45.4% in the 1st quarter.

Source: https://www.americanbankingnews.com/2023/01/14/international-assets-investment-management-llc-grows-holdings-in-novo-nordisk-a-s-nysenvo.html

By expanding its manufacturing capacity, Lilly could avoid some of the manufacturing constraints that encountered by rival Novo Nordisk and its weight loss drug, Wegovy.

Source: https://medcitynews.com/2023/11/eli-lilly-plans-new-2-5b-manufacturing-site-in-germany-for-injectable-meds/

Comerica Bank trimmed its stake in shares of Novo Nordisk A/S () by 4.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission.

Source: https://www.etfdailynews.com/2023/04/12/comerica-bank-has-5-87-million-stake-in-novo-nordisk-a-s-nysenvo/

Corporate donations from other industries included $1,000 from Exelon Corp., $1,000 from Kraft Heinz Co. and $2,500 from pharmaceutical company Novo Nordisk.

Source: https://www.dailyherald.com/news/20231023/democratic-challenger-outraised-rep-foster-in-third-quarter-x2014-but-can-he-win

Dynamic Advisor Solutions LLC’s holdings in Novo Nordisk A/S were worth $2,667,000 as of its most recent SEC filing.

Source: https://www.americanbankingnews.com/2023/12/21/dynamic-advisor-solutions-llc-boosts-stake-in-novo-nordisk-a-s-nysenvo.html

For now, the GLP-1 drug and generative AI hypes appear to have taken the stock market by storm, with many companies similarly benefitting from the boom, namely Novo Nordisk () for the former and NVIDIA (

Source: https://seekingalpha.com/article/4656935-medtronic-the-glp-1-drug-headwinds-are-overblown?source=feed_all_articles

Juleen Zierath funding from the Swedish Research Council, Swedish Diabetes Foundation, Swedish Research Council for Sport Science and Novo Nordisk Foundation.

Source: https://theconversation.com/morning-exercise-burns-more-body-fat-mouse-study-shows-200130

Manufactured by the Danish firm Novo Nordisk, the drug was initially developed to treat type 2 diabetes in 2012.

Source: https://www.dailymail.co.uk/health/article-11900239/Experts-warn-Ozempic-causing-wave-plastic-surgeries-fix-loose-skin.html?ns_mchannel=rss&ns_campaign=1490&ito=1490

Novo Nordisk A/S has a 12-month low of $95.02 and a 12-month high of $172.97.

Source: https://www.americanbankingnews.com/2023/06/08/bessemer-group-inc-grows-stock-position-in-novo-nordisk-a-s-nysenvo.html

Novo Nordisk chose to ramp up production before making it available in Britain, with labs working 24/7.

Source: https://www.dailymail.co.uk/health/article-12209961/Government-BANS-companies-exporting-miracle-fat-fighting-drugs-like-Ozempic.html?ns_mchannel=rss&ns_campaign=1490&ito=1490

Novo Nordisk credited this rise - up by a third, or £1.3billion, on the previous spell - to the sky-high demand for its weekly semaglutide jabs.

Source: https://www.dailymail.co.uk/health/article-12482393/How-pharmaceutical-titan-Wegovy-raked-4-5billion-success-weight-loss-jab-stock-drug-arrives-Britain.html?ns_mchannel=rss&ns_campaign=1490&ito=1490

Novo Nordisk (NVO) shares are surging, up 51% in 2023.

Source: https://forextv.com/crypto-currency-news/novo-nordisk-relentless-inflows-send-shares-soaring/

Novo Nordisk plans to invest €2.1bn to expand production in France as it works to meet surging demand for its sought-after weight-loss medicines.

Source: https://www.irishexaminer.com/business/companies/arid-41275936.html

Ozempic is a brand-name diabetes medication manufactured by Novo Nordisk, but the medical ingredient in it is called semaglutide.

Source: https://globalnews.ca/news/9621878/tougher-rules-may-curb-us-bound-drugs-minister/

Sell-side analysts expect that Novo Nordisk A/S will post 2.61 earnings per share for the current year.

Source: https://www.dailypolitical.com/2023/12/20/boston-common-asset-management-llc-trims-holdings-in-novo-nordisk-a-s-nysenvo.html

The success of these treatments, especially from companies such as Novo Nordisk and Eli Lilly, has attracted the attention of celebrities, including Tesla chief executive Elon Musk and former British prime minister Boris Johnson.

Source: https://www.irishexaminer.com/business/companies/arid-41171611.html

Under the programme initiated 9 May 2023, Novo Nordisk will repurchase B shares for an amount up to DKK 5.8 billion in the period from 10 May 2023 to 8 August 2023.

Source: https://www.marketscreener.com/quote/stock/NOVO-NORDISK-A-S-1412980/news/Novo-Nordisk-A-S-share-repurchase-programme-44140926/?utm_medium=RSS&utm_content=20230619

We work closely with the U.S. Food and Drug Administration to continuously monitor the safety profile of our medicines," a media representative at Novo Nordisk explained.

Source: https://www.salon.com/2023/10/08/new-side-effects-from-ozempic-are-emerging-as-more-take-the-drug-experts-explain-how-to-manage-them/